Polymer of proline analogue with sustained antifibrotic activity in lung fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 4, 1997, Pages 1391-1397

  Greco, Mark J ^a   Kemnitzer, John E ^a   Fox, James D ^a   Choe, Jin K ^a   Kohn, Joachim ^a   Riley, David J ^a   Poiani, George J ^a  

^a Department of Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BLEOMYCIN SULFATE; COLLAGEN; COPOLYMER; HYDROXYPROLINE; LYSINE; MACROGOL; PROLINE DERIVATIVE; PROTEIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG RETENTION; INTRATRACHEAL DRUG ADMINISTRATION; LUNG FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

EID: 0030896243     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.4.9105084     Document Type: Article

References (32)

1. Hunninghake, G. W., and A. R. Kalica. 1995. Approaches to the treatment of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 151: 915-918.
2. Gauldie, J., M. Jordana, and G. Cox. 1993. Cytokines and pulmonary fibrosis. Thorax 48:931-935.
3. Kovacs, E. J., and L. A. DiPietro. 1994. Fibrogenic cytokines and connective tissue production. FASEB J. 8:854-861.
4. Piguet, P. F. 1993. Cytokines involved in pulmonary fibrosis. Int. Rev. Exp. Pathol. 34:173-181.
5. Franklin, T. J. 1995. Current approaches to the therapy of fibrotic disease. Biochem. Pharmacol. 49:267-273.
6. Uitto, J., L. Ryhänen, E. M. L. Tan, A. I. Oikarinen, and E. J. Zaragoza. 1984. Pharmacological inhibition of excessive collagen deposition in fibrotic diseases. Fed. Proc. 43:2815-2820.
7. Prockop, D. J., and K. I. Kivirikko. 1995. Collagens: molecular biology, diseases, and potentials for therapy. Annu. Rev. Biochem. 64: 403-434.
8. Wilson, M. J., and D. L. Hatfield. 1984. Incorporation of modified amino acids into proteins in vivo. Biochem. Biophys. Acta 781:205-215.
9. Salvador, R. A., C. Fiedler-Nagy, and J. W. Coffey. 1985. Biochemical basis for drug therapy to prevent pulmonary fibrosis in ARDS. In W. M. Zapol and K. J. Falke, editors. Acute Respiratory Failure. Marcel Dekker, New York. 477-506.
10. Uitto, J., and D. J. Prockop. 1974. Incorporation of proline analogues into collagen polypeptides: effects of the production of extracellular procollagen and on the stability of the triple-helical structure of the molecule. Biochim. Biophys. Acta 336:234-251.
11. Berg, R. A., M. L. Schwartz, and R. G. Crystal. 1978. Regulation of the production of secretory proteins: intracellular degradation of newly synthesized "defective" collagen. Proc. Natl. Acad. Sci. U.S.A. 75:451-453.
12. Eldridge, C. F., R. P. Bunge, and M. E. Bunge. 1988. Effects of cis-4-hydroxy-L-proline, an inhibitor of Schwann cell differentiation, on the secretion of collagenous and noncollagenous proteins by Schwann cells. Exp. Cell Res. 174:491-501.
13. Poiani, G. J., D. J. Riley, J. D. Fox, J. E. Kemnitzer, K. F. Gean, and J. Kohn. 1994. Conjugates of cis-4-hydroxy-L-proline and poly-(PEG-Lys), a water soluble poly(ether urethane): synthesis and evaluation of antifibrotic effects in vitro and in vivo. Bioconjug. Chem. 5:621-630.
14. Harris, J. M. 1992. Poly(ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications. Plenum Press, New York.
15. Poiani, G. J., F. J. Wilson, J. D. Fox, J. M. Sumka, B. W. Peng, W. C. Liao, C. A. Tozzi, and D. J. Riley. 1992. Liposome-entrapped antifibrotic agent prevents collagen accumulation in hypertensive pulmonary arteries of rats. Circ. Res. 70:912-922.
16. Chen, P. S., T. Y. Toribara, and H. Werner. 1956. Microdetermination of phosphorus. Anal. Chem. 28:1756-1758.
17. Ames, B. N., and D. T. Dubin. 1960. The role of polyamines in the neutralization of bacteriophage deoxyribonucleic acid. J. Biol. Chem. 235:769-775.
18. Costa, D. L., J. R. Lehmann, W. M. Harold, and R. T. Drew. 1986. Transoral tracheal intubation of rodents using a fiberoptic laryngoscope. Lab. Anim. Sci. 36:256-261.
19. Pratt, P. C., R. I. Vollmer, J. D. Shelburne, and J. D. Crapo. 1979. Pulmonary morphology in a multi-hospital collaborative extracorporeal membrane oxygenation project. 1. Light microscopy. Am. J. Pathol. 95:191-214.
20. Kivirikko, K. O., O. Laitinen, and D. J. Prockop. 1967. Modifications of a specific assay for hydroxyproline in urine. Anal. Biochem. 19:249-255.
21. Moore, S., and W. H. Stein. 1948. Photometric ninhydrin method for use in the chromatography of amino acids. J. Biol. Chem. 176:367-388.
22. cells factor in the normal and splenectomized Sherman rat. Am. J. Physiol. 196:188-192.
23. Hughes, B. J., S. Kennel, R. Lee, and L. Huang. 1989. Monoclonal antibody targeting of liposomes in mouse lung in vivo. Cancer Res. 49:6214-6220.
24. Phan, S. H., R. S. Thrall, and P. A. Ward. 1980. Bleomycin induced pulmonary fibrosis in rats: biochemical demonstration of increased rat of collagen synthesis. Am. Rev. Respir. Dis. 121:501-506.
25. SAS Institute, Inc. 1985. SAS User's Guide: Statistics. SAS Institute, Inc., Cary, NC. 119-137.
26. Duncan, D. B. 1975. t Tests and intervals for comparisons suggested by the data. Biometrics 31:339-359.
27. Langer, R. 1990. New methods for drug delivery. Science 249:1527-1533.
28. Clark, R. A. 1991. The commonality of cutaneous wound repair and lung injury. Chest 99:57S-60S.
29. Wall, D. A. 1995. Pulmonary absorption of peptides and proteins. Drug Deliv. 2:1-20.
30. Nathan, A., S. Zalipsky, S. I. Ertel, S. N. Agathos, M. L. Yarmush, and J. Kohn. 1993. Copolymers of lysine and polyethylene glycol: a new family of functionalized drug carriers. Bioconjug. Chem. 4: 54-62.
31. Gonzalez-Rothi, R. J., L. Straub, J. L. Cacace, and H. Schreier. 1991. Liposomes and pulmonary alveolar macrophages: functional and morphologic interactions. Exp. Lung Res. 17:687-705.
32. Riley, D. J., J. S. Kerr, R. A. Berg, B. D. Ianni, G. G. Pietra, N. H. Edelman, and D. J. Prockop. 1981. Prevention of bleomycin-induced pulmonary fibrosis in the hamster by cis-4-hydroxy-L-proline. Am. Rev. Respir. Dis. 123:388-393.